AMARIN CORP PLC\UK Increase (Decrease) in Other Noncurrent Liabilities
AMARIN CORP PLC\UK (AMRN) reported Increase (Decrease) in Other Noncurrent Liabilities of $414.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-07-29
- AMARIN CORP PLC\UK increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was $291.00K, a 26.70% decline year-over-year.
- AMARIN CORP PLC\UK increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was $123.00K.
- AMARIN CORP PLC\UK increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was -$927.00K, a 148.03% decline year-over-year.
- AMARIN CORP PLC\UK increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was -$115.00K.
- AMARIN CORP PLC\UK increase (decrease) in other noncurrent liabilities for fiscal 2025 was -$1.06M, a 149.42% decline from fiscal 2024.
- AMARIN CORP PLC\UK increase (decrease) in other noncurrent liabilities for fiscal 2024 was $2.14M, a 520.58% increase from fiscal 2023.
- AMARIN CORP PLC\UK increase (decrease) in other noncurrent liabilities for fiscal 2023 was $345.00K, a 40.62% decline from fiscal 2022.
- AMARIN CORP PLC\UK increase (decrease) in other noncurrent liabilities for fiscal 2022 was $581.00K, a 53.63% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $291.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $414.00K 10-Q · filed 2026-07-29 | -$513.00K derived: sum of 3 quarters · filed 2026-07-29 | -$628.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $123.00K 10-Q · filed 2026-04-29 | -$804.00K derived: sum of 2 quarters · filed 2026-04-29 | -$919.00K derived: sum of 3 quarters · filed 2026-04-29 | -$522.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$927.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$1.04M derived: sum of 2 quarters · filed 2026-03-02 | -$645.00K derived: sum of 3 quarters · filed 2026-07-29 | -$1.06M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $282.00K derived: sum of 2 quarters · filed 2026-07-29 | -$131.00K 10-Q · filed 2025-10-29 | $1.80M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $397.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$16.00K 10-Q · filed 2026-07-29 | $1.91M derived: sum of 3 quarters · filed 2026-07-29 | $1.72M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$413.00K 10-Q · filed 2026-04-29 | $1.52M derived: sum of 2 quarters · filed 2026-04-29 | $1.32M derived: sum of 3 quarters · filed 2026-04-29 | $1.51M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.74M derived: sum of 2 quarters · filed 2026-03-02 | $1.92M derived: sum of 3 quarters · filed 2026-03-02 | $2.14M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$10.00K derived: sum of 2 quarters · filed 2025-10-29 | $211.00K 10-Q · filed 2025-10-29 | $1.97M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $403.00K 10-Q · filed 2025-07-30 | $2.16M derived: sum of 3 quarters · filed 2026-03-02 | $2.25M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $221.00K 10-Q · filed 2025-05-07 | $1.98M derived: sum of 2 quarters · filed 2026-03-02 | $2.06M derived: sum of 3 quarters · filed 2026-03-02 | $451.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.84M derived: sum of 2 quarters · filed 2026-03-02 | $230.00K derived: sum of 3 quarters · filed 2026-03-02 | $345.00K 10-K · filed 2026-03-02 |
| 2023-09-30 | $84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$1.53M derived: sum of 2 quarters · filed 2024-10-30 | -$1.41M 10-Q · filed 2024-10-30 | -$3.43M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-06-30 | -$1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$1.50M 10-Q · filed 2024-07-31 | -$3.51M derived: sum of 3 quarters · filed 2025-03-12 | -$1.56M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-03-31 | $115.00K 10-Q · filed 2024-05-01 | -$1.90M derived: sum of 2 quarters · filed 2025-03-12 | $49.00K derived: sum of 3 quarters · filed 2025-03-12 | $61.00K derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$66.00K derived: sum of 2 quarters · filed 2025-03-12 | -$54.00K derived: sum of 3 quarters · filed 2025-03-12 | $581.00K 10-K · filed 2025-03-12 |
| 2022-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $1.96M derived: sum of 2 quarters · filed 2023-11-01 | $2.60M 10-Q · filed 2023-11-01 | $4.84M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $647.00K 10-Q · filed 2023-08-02 | $2.90M derived: sum of 3 quarters · filed 2024-02-29 | $2.67M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $635.00K 10-Q · filed 2023-05-03 | $2.88M derived: sum of 2 quarters · filed 2024-02-29 | $2.66M derived: sum of 3 quarters · filed 2024-02-29 | $2.48M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.03M derived: sum of 2 quarters · filed 2024-02-29 | $1.85M derived: sum of 3 quarters · filed 2024-02-29 | $1.25M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$222.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$399.00K derived: sum of 2 quarters · filed 2022-10-27 | -$995.00K 10-Q · filed 2022-10-27 | $907.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$177.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$773.00K 10-Q · filed 2022-08-03 | $1.13M derived: sum of 3 quarters · filed 2023-03-01 | $697.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$596.00K 10-Q · filed 2022-05-04 | $1.31M derived: sum of 2 quarters · filed 2023-03-01 | $874.00K derived: sum of 3 quarters · filed 2023-03-01 | $3.07M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.47M derived: sum of 2 quarters · filed 2023-03-01 | $3.66M derived: sum of 3 quarters · filed 2023-03-01 | $2.63M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$432.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $1.76M derived: sum of 2 quarters · filed 2021-11-03 | $727.00K 10-Q · filed 2021-11-03 | -$791.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.16M 10-Q · filed 2021-08-05 | -$359.00K derived: sum of 3 quarters · filed 2022-03-01 | -$1.50M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$1.03M 10-Q · filed 2021-04-29 | -$2.55M derived: sum of 2 quarters · filed 2022-03-01 | -$3.69M derived: sum of 3 quarters · filed 2022-03-01 | -$4.50M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$2.65M derived: sum of 2 quarters · filed 2022-03-01 | -$3.47M derived: sum of 3 quarters · filed 2022-03-01 | -$5.84M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$1.95M derived: sum of 2 quarters · filed 2020-11-05 | -$4.32M 10-Q · filed 2020-11-05 | -$2.45M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$817.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$3.19M 10-Q · filed 2020-08-04 | -$1.31M derived: sum of 3 quarters · filed 2021-02-25 | $573.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$2.37M 10-Q · filed 2020-04-30 | -$498.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.39M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2018-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.76M derived: sum of 2 quarters · filed 2021-02-25 | $9.37M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $7.50M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $5.61M 10-Q · filed 2019-07-31 | |||
| 2017-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$8.00K derived: sum of 2 quarters · filed 2020-02-25 | -$17.00K derived: sum of 3 quarters · filed 2020-02-25 | $440.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$9.00K derived: sum of 2 quarters · filed 2018-11-01 | $448.00K 10-Q · filed 2018-11-01 | $427.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $448.00K 10-Q · filed 2018-08-01 | $427.00K derived: sum of 3 quarters · filed 2019-02-27 | $890.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $457.00K 10-Q · filed 2018-05-02 | $436.00K derived: sum of 2 quarters · filed 2019-02-27 | $899.00K derived: sum of 3 quarters · filed 2019-02-27 | $867.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $442.00K derived: sum of 2 quarters · filed 2019-02-27 | $410.00K derived: sum of 3 quarters · filed 2019-02-27 | $375.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | $463.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $431.00K derived: sum of 2 quarters · filed 2017-11-01 | $396.00K 10-Q · filed 2017-11-01 | $123.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$67.00K 10-Q · filed 2017-08-02 | -$340.00K derived: sum of 3 quarters · filed 2018-02-27 | -$358.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$35.00K 10-Q · filed 2017-05-03 | -$308.00K derived: sum of 2 quarters · filed 2018-02-27 | -$326.00K derived: sum of 3 quarters · filed 2018-02-27 | -$331.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$291.00K derived: sum of 2 quarters · filed 2018-02-27 | -$296.00K derived: sum of 3 quarters · filed 2018-02-27 | -$51.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$23.00K derived: sum of 2 quarters · filed 2016-11-03 | $222.00K 10-Q · filed 2016-11-03 | |
| 2015-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $240.00K 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $245.00K 10-Q · filed 2016-05-05 | |||
| 2012-03-31 | $2.79M 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |